Aims & Scope
Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews,
thematic issues, rapid technical notes and commentaries that provide insights
into the synthesis, characterisation and pharmaceutical (or diagnostic)
application of materials at the nanoscale. The nanoscale is defined as a size
range of below 1 µm. Scientific findings related to micro and macro systems
with functionality residing within features defined at the nanoscale are also
within the scope of the journal. Manuscripts detailing the synthesis,
exhaustive characterisation, biological evaluation, clinical testing and/or toxicological
assessment of nanomaterials are of particular interest to the journal’s
readership. Articles should be self contained, centred around a well founded
hypothesis and should aim to showcase the pharmaceutical/diagnostic
implications of the nanotechnology approach. Manuscripts should aim, wherever
possible, to demonstrate the in vivo impact of any nanotechnological
intervention. As reducing a material to the nanoscale is capable of
fundamentally altering the material’s properties, the journal’s readership is
particularly interested in new characterisation techniques and the advanced
properties that originate from this size reduction. Both bottom up and top down
approaches to the realisation of nanomaterials lie within the scope of the
journal.
